Highlights

array(40) {
  [0]=>
  string(4) "5321"
  ["article_id"]=>
  string(4) "5321"
  [1]=>
  string(47) "11th Annual NGS & Clinical Diagnostics Congress"
  ["article_title"]=>
  string(47) "11th Annual NGS & Clinical Diagnostics Congress"
  [2]=>
  string(150) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series prov"
  ["short_description"]=>
  string(150) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series prov"
  [3]=>
  string(511) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally reno..."
  ["description"]=>
  string(511) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally reno..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(77) "https://www.pharmiweb.com/event/11th-annual-ngs-clinical-diagnostics-congress"
  ["blog_url"]=>
  string(77) "https://www.pharmiweb.com/event/11th-annual-ngs-clinical-diagnostics-congress"
  [15]=>
  string(19) "2019-03-26 14:53:21"
  ["add_date"]=>
  string(19) "2019-03-26 14:53:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

11th Annual NGS & Clinical Diagnostics Congress

The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts u

array(40) {
  [0]=>
  string(4) "5322"
  ["article_id"]=>
  string(4) "5322"
  [1]=>
  string(40) "7th Annual Single Cell Analysis Congress"
  ["article_title"]=>
  string(40) "7th Annual Single Cell Analysis Congress"
  [2]=>
  string(150) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series prov"
  ["short_description"]=>
  string(150) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series prov"
  [3]=>
  string(507) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine And Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally renown..."
  ["description"]=>
  string(507) "The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine And Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally renown..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(72) "https://www.pharmiweb.com/event/7th-annual-single-cell-analysis-congress"
  ["blog_url"]=>
  string(72) "https://www.pharmiweb.com/event/7th-annual-single-cell-analysis-congress"
  [15]=>
  string(19) "2019-03-26 14:45:52"
  ["add_date"]=>
  string(19) "2019-03-26 14:45:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

7th Annual Single Cell Analysis Congress

The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts u

array(40) {
  [0]=>
  string(4) "2008"
  ["article_id"]=>
  string(4) "2008"
  [1]=>
  string(111) "Astellas Presents Fezolinetant Phase 2b Clinical Trial Results at Endocrine Society's Annual Meeting (ENDO)"
  ["article_title"]=>
  string(111) "Astellas Presents Fezolinetant Phase 2b Clinical Trial Results at Endocrine Society's Annual Meeting (ENDO)"
  [2]=>
  string(150) "TOKYO, March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced"
  ["short_description"]=>
  string(150) "TOKYO, March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced"
  [3]=>
  string(252) "TOKYO, March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced results from a Phase 2b dose-finding study of fezolinetant, presented in an oral session (Abstract..."
  ["description"]=>
  string(252) "TOKYO, March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced results from a Phase 2b dose-finding study of fezolinetant, presented in an oral session (Abstract..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/astellas-presents-fezolinetant-phase-2b-clinical-trial-results-endocrine-society-s-annual-meeting-18113.html?utm_source=ddc&utm_medium=rss&utm_campaign=Astellas+Presents+Fezolinetant+Phase+2b+Clinical+Trial+Results+at+Endocrine+Society%27s+Annual+Meeting+%28ENDO"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/astellas-presents-fezolinetant-phase-2b-clinical-trial-results-endocrine-society-s-annual-meeting-18113.html?utm_source=ddc&utm_medium=rss&utm_campaign=Astellas+Presents+Fezolinetant+Phase+2b+Clinical+Trial+Results+at+Endocrine+Society%27s+Annual+Meeting+%28ENDO"
  [15]=>
  string(19) "2019-03-26 14:04:49"
  ["add_date"]=>
  string(19) "2019-03-26 14:04:49"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Astellas Presents Fezolinetant Phase 2b Clinical Trial Results at Endocrine Society's

TOKYO, March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "A

array(40) {
  [0]=>
  string(4) "1793"
  ["article_id"]=>
  string(4) "1793"
  [1]=>
  string(66) "Medical News Today: Colloidal silver: Does it work and is it safe?"
  ["article_title"]=>
  string(66) "Medical News Today: Colloidal silver: Does it work and is it safe?"
  [2]=>
  string(150) "Colloidal silver is a popular home remedy, and people use it to treat or prevent a range of health issues. However, the solution may not be safe to in"
  ["short_description"]=>
  string(150) "Colloidal silver is a popular home remedy, and people use it to treat or prevent a range of health issues. However, the solution may not be safe to in"
  [3]=>
  string(211) "Colloidal silver is a popular home remedy, and people use it to treat or prevent a range of health issues. However, the solution may not be safe to ingest, and it can have serious side effects. Learn more here. "
  ["description"]=>
  string(211) "Colloidal silver is a popular home remedy, and people use it to treat or prevent a range of health issues. However, the solution may not be safe to ingest, and it can have serious side effects. Learn more here. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/324793.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/324793.php"
  [15]=>
  string(19) "2019-03-26 14:00:00"
  ["add_date"]=>
  string(19) "2019-03-26 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-28 09:47:12"
  ["create_at"]=>
  string(19) "2019-03-28 09:47:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical News Today: Colloidal silver: Does it work and is it safe?

Colloidal silver is a popular home remedy, and people use it to treat or prevent a range of health issues. However, the

array(40) {
  [0]=>
  string(4) "5320"
  ["article_id"]=>
  string(4) "5320"
  [1]=>
  string(30) "Inaugural Digital PCR Congress"
  ["article_title"]=>
  string(30) "Inaugural Digital PCR Congress"
  [2]=>
  string(155) "The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics experts under one roof. The series provid"
  ["short_description"]=>
  string(155) "The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics experts under one roof. The series provid"
  [3]=>
  string(510) "The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine and Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally renown..."
  ["description"]=>
  string(510) "The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine and Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.&#nlWe will have over 600 end users representing internationally renown..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(62) "https://www.pharmiweb.com/event/inaugural-digital-pcr-congress"
  ["blog_url"]=>
  string(62) "https://www.pharmiweb.com/event/inaugural-digital-pcr-congress"
  [15]=>
  string(19) "2019-03-26 12:49:24"
  ["add_date"]=>
  string(19) "2019-03-26 12:49:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Inaugural Digital PCR Congress

The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics expert

array(40) {
  [0]=>
  string(4) "1794"
  ["article_id"]=>
  string(4) "1794"
  [1]=>
  string(55) "Medical News Today: What causes a constant urge to pee?"
  ["article_title"]=>
  string(55) "Medical News Today: What causes a constant urge to pee?"
  [2]=>
  string(150) "Infections and other bladder issues can affect the way a person urinates. Some conditions can cause a constant urge to pee, even when doing so produce"
  ["short_description"]=>
  string(150) "Infections and other bladder issues can affect the way a person urinates. Some conditions can cause a constant urge to pee, even when doing so produce"
  [3]=>
  string(239) "Infections and other bladder issues can affect the way a person urinates. Some conditions can cause a constant urge to pee, even when doing so produces little urine. In this article, we look at causes, treatments, and when to see a doctor."
  ["description"]=>
  string(239) "Infections and other bladder issues can affect the way a person urinates. Some conditions can cause a constant urge to pee, even when doing so produces little urine. In this article, we look at causes, treatments, and when to see a doctor."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/324795.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/324795.php"
  [15]=>
  string(19) "2019-03-26 12:00:00"
  ["add_date"]=>
  string(19) "2019-03-26 12:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-28 09:47:12"
  ["create_at"]=>
  string(19) "2019-03-28 09:47:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical News Today: What causes a constant urge to pee?

Infections and other bladder issues can affect the way a person urinates. Some conditions can cause a constant urge to p

array(40) {
  [0]=>
  string(4) "1795"
  ["article_id"]=>
  string(4) "1795"
  [1]=>
  string(54) "Medical News Today: When to consume protein: The facts"
  ["article_title"]=>
  string(54) "Medical News Today: When to consume protein: The facts"
  [2]=>
  string(150) "Consuming protein is necessary for muscle growth and repair. There is no single best time for this, but rather it depends on individual goals. Learn m"
  ["short_description"]=>
  string(150) "Consuming protein is necessary for muscle growth and repair. There is no single best time for this, but rather it depends on individual goals. Learn m"
  [3]=>
  string(186) "Consuming protein is necessary for muscle growth and repair. There is no single best time for this, but rather it depends on individual goals. Learn more about when to have protein here."
  ["description"]=>
  string(186) "Consuming protein is necessary for muscle growth and repair. There is no single best time for this, but rather it depends on individual goals. Learn more about when to have protein here."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/324790.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/324790.php"
  [15]=>
  string(19) "2019-03-26 10:00:00"
  ["add_date"]=>
  string(19) "2019-03-26 10:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-28 09:47:12"
  ["create_at"]=>
  string(19) "2019-03-28 09:47:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical News Today: When to consume protein: The facts

Consuming protein is necessary for muscle growth and repair. There is no single best time for this, but rather it depend

array(40) {
  [0]=>
  string(4) "1796"
  ["article_id"]=>
  string(4) "1796"
  [1]=>
  string(60) "Medical News Today: What are the symptoms of ADHD in adults?"
  ["article_title"]=>
  string(60) "Medical News Today: What are the symptoms of ADHD in adults?"
  [2]=>
  string(150) "The symptoms of ADHD in adults vary depending on the type of ADHD, but they may include disorganization and restlessness. Learn more about adult ADHD "
  ["short_description"]=>
  string(150) "The symptoms of ADHD in adults vary depending on the type of ADHD, but they may include disorganization and restlessness. Learn more about adult ADHD "
  [3]=>
  string(164) "The symptoms of ADHD in adults vary depending on the type of ADHD, but they may include disorganization and restlessness. Learn more about adult ADHD symptoms here."
  ["description"]=>
  string(164) "The symptoms of ADHD in adults vary depending on the type of ADHD, but they may include disorganization and restlessness. Learn more about adult ADHD symptoms here."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/324789.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/324789.php"
  [15]=>
  string(19) "2019-03-26 08:00:00"
  ["add_date"]=>
  string(19) "2019-03-26 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-28 09:47:12"
  ["create_at"]=>
  string(19) "2019-03-28 09:47:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical News Today: What are the symptoms of ADHD in adults?

The symptoms of ADHD in adults vary depending on the type of ADHD, but they may include disorganization and restlessness

array(40) {
  [0]=>
  string(4) "1941"
  ["article_id"]=>
  string(4) "1941"
  [1]=>
  string(106) "Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis"
  ["article_title"]=>
  string(106) "Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis"
  [2]=>
  string(150) "SUMMIT, N.J.--(BUSINESS WIRE)--March 25, 2019 Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application "
  ["short_description"]=>
  string(150) "SUMMIT, N.J.--(BUSINESS WIRE)--March 25, 2019 Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application "
  [3]=>
  string(245) "SUMMIT, N.J.--(BUSINESS WIRE)--March 25, 2019 Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with..."
  ["description"]=>
  string(245) "SUMMIT, N.J.--(BUSINESS WIRE)--March 25, 2019 Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(196) "https://www.drugs.com/nda/ozanimod_190325.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Submits+Application+to+FDA+for+Ozanimod+for+the+Treatment+of+Relapsing+Forms+of+Multiple+Sclerosis"
  ["blog_url"]=>
  string(196) "https://www.drugs.com/nda/ozanimod_190325.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Submits+Application+to+FDA+for+Ozanimod+for+the+Treatment+of+Relapsing+Forms+of+Multiple+Sclerosis"
  [15]=>
  string(19) "2019-03-26 05:03:16"
  ["add_date"]=>
  string(19) "2019-03-26 05:03:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Mu

SUMMIT, N.J.--(BUSINESS WIRE)--March 25, 2019 Celgene Corporation (NASDAQ:CELG) today announced that the Company has sub

array(40) {
  [0]=>
  string(4) "1797"
  ["article_id"]=>
  string(4) "1797"
  [1]=>
  string(62) "Medical News Today: What are the health benefits of jackfruit?"
  ["article_title"]=>
  string(62) "Medical News Today: What are the health benefits of jackfruit?"
  [2]=>
  string(150) "Jackfruit is a healthful source of essential nutrients, including vitamin C, potassium, and dietary fiber. Research suggests that substances in the fr"
  ["short_description"]=>
  string(150) "Jackfruit is a healthful source of essential nutrients, including vitamin C, potassium, and dietary fiber. Research suggests that substances in the fr"
  [3]=>
  string(303) "Jackfruit is a healthful source of essential nutrients, including vitamin C, potassium, and dietary fiber. Research suggests that substances in the fruit and plant may have a variety of health benefits. Cooked, unripe jackfruit is a popular meat substitute among vegetarians and vegans. Learn more here."
  ["description"]=>
  string(303) "Jackfruit is a healthful source of essential nutrients, including vitamin C, potassium, and dietary fiber. Research suggests that substances in the fruit and plant may have a variety of health benefits. Cooked, unripe jackfruit is a popular meat substitute among vegetarians and vegans. Learn more here."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/324787.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/324787.php"
  [15]=>
  string(19) "2019-03-26 04:00:00"
  ["add_date"]=>
  string(19) "2019-03-26 04:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-28 09:47:12"
  ["create_at"]=>
  string(19) "2019-03-28 09:47:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical News Today: What are the health benefits of jackfruit?

Jackfruit is a healthful source of essential nutrients, including vitamin C, potassium, and dietary fiber. Research sugg

array(40) {
  [0]=>
  string(4) "1978"
  ["article_id"]=>
  string(4) "1978"
  [1]=>
  string(53) "A day in the life of a pharmaceutical patent attorney"
  ["article_title"]=>
  string(53) "A day in the life of a pharmaceutical patent attorney"
  [2]=>
  string(72) "Bal Matharu details a typical day at intellectual property firm HGF Ltd."
  ["short_description"]=>
  string(72) "Bal Matharu details a typical day at intellectual property firm HGF Ltd."
  [3]=>
  string(72) "Bal Matharu details a typical day at intellectual property firm HGF Ltd."
  ["description"]=>
  string(72) "Bal Matharu details a typical day at intellectual property firm HGF Ltd."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(158) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-profile/a-day-in-the-life-of-a-pharmaceutical-patent-attorney/20206176.article"
  ["blog_url"]=>
  string(158) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-profile/a-day-in-the-life-of-a-pharmaceutical-patent-attorney/20206176.article"
  [15]=>
  string(19) "2019-03-25 23:42:00"
  ["add_date"]=>
  string(19) "2019-03-25 23:42:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:55"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

A day in the life of a pharmaceutical patent attorney

Bal Matharu details a typical day at intellectual property firm HGF Ltd.

array(40) {
  [0]=>
  string(4) "2188"
  ["article_id"]=>
  string(4) "2188"
  [1]=>
  string(138) "Coherus BioSciences announced global settlement with AbbVie securing rights to commercialize its adalimumab biosimilar candidate, CHS-1420"
  ["article_title"]=>
  string(138) "Coherus BioSciences announced global settlement with AbbVie securing rights to commercialize its adalimumab biosimilar candidate, CHS-1420"
  [2]=>
  string(150) "Coherus BioSciences, Inc., announced it has executed settlement agreements with AbbVie Inc. that grant Coherus global, non-exclusive license rights un"
  ["short_description"]=>
  string(150) "Coherus BioSciences, Inc., announced it has executed settlement agreements with AbbVie Inc. that grant Coherus global, non-exclusive license rights un"
  [3]=>
  string(775) "Coherus BioSciences, Inc., announced it has executed settlement agreements with AbbVie Inc. that grant Coherus global, non-exclusive license rights under AbbVie’s intellectual property to commercialize CHS-1420, Coherus’ proposed adalimumab (Humira) biosimilar. The global settlements resolve all pending disputes between the parties related to Coherus’ adalimumab biosimilar. Under the U.S. settlement, Coherus’ license period in the U.S. commences on December 15, 2023. Coherus will pay royalties to AbbVie. Financial terms are not disclosed. “Biosimilars have an essential role in our healthcare […]""/"
  ["description"]=>
  string(775) "Coherus BioSciences, Inc., announced it has executed settlement agreements with AbbVie Inc. that grant Coherus global, non-exclusive license rights under AbbVie’s intellectual property to commercialize CHS-1420, Coherus’ proposed adalimumab (Humira) biosimilar. The global settlements resolve all pending disputes between the parties related to Coherus’ adalimumab biosimilar. Under the U.S. settlement, Coherus’ license period in the U.S. commences on December 15, 2023. Coherus will pay royalties to AbbVie. Financial terms are not disclosed. “Biosimilars have an essential role in our healthcare […]""/"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "43"
  ["rss_id"]=>
  string(2) "43"
  [14]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/PrJbkKFhSVw/"
  ["blog_url"]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/PrJbkKFhSVw/"
  [15]=>
  string(19) "2019-03-25 18:48:45"
  ["add_date"]=>
  string(19) "2019-03-25 18:48:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:41"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Coherus BioSciences announced global settlement with AbbVie securing rights to commerciali

Coherus BioSciences, Inc., announced it has executed settlement agreements with AbbVie Inc. that grant Coherus global, n